Parole chiave di "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes"

Label

• Parole chiave di "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" (literal)
• Keywords of "Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes" (literal)

Insieme di parole chiave di

• Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes (Articolo in rivista) (Prodotto della ricerca)

Ha membro

• Type 2 diabetes (Parola chiave)
• Sodiumglucoseco-transporter2 inhibitor (Parola chiave)
• Beta cell function (Parola chiave)
• SGLT2 (Parola chiave)
• Canagliflozin (Parola chiave)
• Insulin secretion (Parola chiave)

Incoming links:

Insieme di parole chiave

• Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes (Articolo in rivista) (Prodotto della ricerca)

Membro di

• Type 2 diabetes (Parola chiave)
• Beta cell function (Parola chiave)
• Insulin secretion (Parola chiave)
• Sodiumglucoseco-transporter2 inhibitor (Parola chiave)
• Canagliflozin (Parola chiave)
• SGLT2 (Parola chiave)